Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins.

The objective of this review is to highlight the advantages of mono- and combination therapy with pioglitazone in comparison with gliptins and to underline the inconsistencies in the medicinal and reimbursement policy in Bulgaria. PMID: 26288659 [PubMed]
Source: Diabetes Metab - Category: Endocrinology Authors: Tags: Diabetol Metab Syndr Source Type: research